About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker KTTA

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Nov 6, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
James Silverman00.0%SCHEDULE 13G/A ↗
Nov 6, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Opaleye, L.P.00.0%SCHEDULE 13G/A ↗
Nov 6, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Opaleye Management Inc.00.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Vivo Opportunity Cayman, LLC937,56710.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Vivo Opportunity Cayman Fund, L.P.937,56710.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Vivo Opportunity, LLC9.29M10.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Vivo Opportunity Fund Holdings, L.P.9.29M10.0%SCHEDULE 13G/A ↗
Jul 31, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
James Silverman2.05M6.1%SCHEDULE 13G/A ↗
Jul 31, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Opaleye, L.P.2.05M6.1%SCHEDULE 13G/A ↗
Jul 31, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Opaleye Management Inc.2.05M6.1%SCHEDULE 13G/A ↗
Jul 1, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Matthew D. Perry3.84M11.5%SCHEDULE 13G/A ↗
Jul 1, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Coastlands Capital LLC3.84M11.5%SCHEDULE 13G/A ↗
Jul 1, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Coastlands Capital GP LLC3.84M11.5%SCHEDULE 13G/A ↗
Jul 1, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Coastlands Capital Partners LP3.84M11.5%SCHEDULE 13G/A ↗
Jul 1, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Coastlands Capital LP3.84M11.5%SCHEDULE 13G/A ↗
Jun 23, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Jon M. Plexico1.95M5.8%SCHEDULE 13G ↗
Jun 23, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Stonepine GP, LLC1.95M5.8%SCHEDULE 13G ↗
Jun 23, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Stonepine Capital, L.P.1.95M5.8%SCHEDULE 13G ↗
Jun 23, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Stonepine Capital Management, LLC1.95M5.8%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Columbia Management Investment Advisers, LLC1.35M5.4%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Ameriprise Financial, Inc.1.35M5.4%SCHEDULE 13G/A ↗
Apr 22, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Jacob Ma-Weaver1.84M7.4%SCHEDULE 13G ↗
Apr 22, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Cable Car Capital, LP1.84M7.4%SCHEDULE 13G ↗
Apr 22, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Funicular Funds, LP1.84M7.4%SCHEDULE 13G ↗
Apr 8, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
James Silverman2.49M10.0%SCHEDULE 13G ↗
Apr 8, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Opaleye, L.P.2.49M10.0%SCHEDULE 13G ↗
Apr 8, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Opaleye Management Inc.2.49M10.0%SCHEDULE 13G ↗
Feb 27, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Matthew D. Perry2.39M10.0%SCHEDULE 13G ↗
Feb 27, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Coastlands Capital LLC2.39M10.0%SCHEDULE 13G ↗
Feb 27, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Coastlands Capital GP LLC2.39M10.0%SCHEDULE 13G ↗
Feb 27, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Coastlands Capital Partners LP2.39M10.0%SCHEDULE 13G ↗
Feb 27, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Coastlands Capital LP2.39M10.0%SCHEDULE 13G ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
William Blank2.33M9.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Matthew Sesterhenn2.33M9.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Squadron Capital Management LLC2.33M9.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Squadron Master Fund LP2.33M9.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
Heights Capital Management, Inc.899,9943.8%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KTTA
Pasithea Therapeutics Corp.
CVI Investments, Inc.899,9943.8%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Columbia Management Investment Advisers, LLC1.93M8.4%SCHEDULE 13G ↗
Feb 17, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Ameriprise Financial, Inc.1.93M8.4%SCHEDULE 13G ↗
Feb 12, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Phillip Gross2.33M10.0%SCHEDULE 13G ↗
Feb 12, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Robert Atchinson2.33M10.0%SCHEDULE 13G ↗
Feb 12, 2026SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Adage Capital Management, L.P.2.33M10.0%SCHEDULE 13G ↗
Dec 8, 2025SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Janus Henderson Group PLC10.23M10.0%SCHEDULE 13G ↗
Dec 5, 2025SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
William Blank2.25M9.9%SCHEDULE 13G ↗
Dec 5, 2025SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Matthew Sesterhenn2.25M9.9%SCHEDULE 13G ↗
Dec 5, 2025SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Squadron Capital Management LLC2.25M9.9%SCHEDULE 13G ↗
Dec 5, 2025SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Squadron Master Fund LP1.65M7.3%SCHEDULE 13G ↗
Dec 5, 2025SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Vivo Opportunity Cayman, LLC1.77M10.0%SCHEDULE 13G ↗
Dec 5, 2025SCHEDULE 13GKTTA
Pasithea Therapeutics Corp.
Vivo Opportunity Cayman Fund, L.P.1.77M10.0%SCHEDULE 13G ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 10:58 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances